Celldex (NASDAQ: CLDX) reported Q1 EPS of ($0.71), $0.03 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $1.18 million versus the consensus estimate of $1.42 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.